BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 30476715)

  • 1. Bleeding and thrombotic events occur early in children on durable ventricular assist devices.
    Huang JY; Ignjatovic V; Sheridan BJ; Mathew J; D'Udekem Y; Brink J; Barton R; Callea G; Morsman D; Donath S; Opat S; Monagle P
    Thromb Res; 2019 Jan; 173():65-70. PubMed ID: 30476715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antithrombotic therapies in children on durable Ventricular Assist Devices: A literature review.
    Huang JY; Monagle P; Massicotte MP; VanderPluym CJ
    Thromb Res; 2018 Dec; 172():194-203. PubMed ID: 29501323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Hematologic and Inflammatory Markers and 31 Thrombotic and Hemorrhagic Events in Berlin Heart Excor Patients.
    Iyengar A; Hung ML; Asanad K; Kwon OJ; Jackson NJ; Reemtsen BL; Federman MD; Biniwale RM
    Pediatr Cardiol; 2017 Apr; 38(4):770-777. PubMed ID: 28184979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapy.
    Slaughter MS; Naka Y; John R; Boyle A; Conte JV; Russell SD; Aaronson KD; Sundareswaran KS; Farrar DJ; Pagani FD
    J Heart Lung Transplant; 2010 Jun; 29(6):616-24. PubMed ID: 20400335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal bleeding and subsequent risk of thromboembolic events during support with a left ventricular assist device.
    Stulak JM; Lee D; Haft JW; Romano MA; Cowger JA; Park SJ; Aaronson KD; Pagani FD
    J Heart Lung Transplant; 2014 Jan; 33(1):60-4. PubMed ID: 24021944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low thromboembolic risk for patients with the Heartmate II left ventricular assist device.
    John R; Kamdar F; Liao K; Colvin-Adams M; Miller L; Joyce L; Boyle A
    J Thorac Cardiovasc Surg; 2008 Nov; 136(5):1318-23. PubMed ID: 19026822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Warfarin and Aspirin Versus Warfarin Alone for Prevention of Embolic Events in Patients with a HeartMate II Left Ventricular Assist Device.
    Van Tuyl JS; Hollis IB; Alburikan KA; Tran RH; Murray BP; Rodgers JE; Katz JN; Sheridan BC
    ASAIO J; 2017; 63(6):731-735. PubMed ID: 28319521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-molecular-weight heparin for anti-coagulation after left ventricular assist device implantation.
    Sandner SE; Riebandt J; Haberl T; Mahr S; Rajek A; Schima H; Wieselthaler GM; Laufer G; Zimpfer D
    J Heart Lung Transplant; 2014 Jan; 33(1):88-93. PubMed ID: 24239003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bivalirudin or Unfractionated Heparin for Anticoagulation in Pediatric Patients on Continuous Flow Ventricular Assist Device Support: Single-Center Retrospective Cohort Study.
    Puri K; Tunuguntla HP; Hensch LA; Loh J; Hui SK; Razavi A; Tume SC; Humlicek TJ; Denfield SW; Spinner JA; Choudhry S; Price JF; Dreyer WJ; Adachi I; Teruya J
    Pediatr Crit Care Med; 2022 Oct; 23(10):e465-e475. PubMed ID: 35687091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilization and Outcomes of Children Treated with Direct Thrombin Inhibitors on Paracorporeal Ventricular Assist Device Support.
    VanderPluym CJ; Cantor RS; Machado D; Boyle G; May L; Griffiths E; Niebler RA; Lorts A; Rossano J; Sutcliffe DL; Lytrivi ID; Buchholz H; Fynn-Thompson F; Hawkins B; Conway J
    ASAIO J; 2020 Aug; 66(8):939-945. PubMed ID: 32740356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel use of cangrelor in pediatrics: A pilot cohort study demonstrating use in ventricular assist devices.
    Fahnhorst SE; Beasley G; Goldberg JF; Martinez HR; Ryan KA; Towbin JA; Boston U; Absi M
    Artif Organs; 2021 Jan; 45(1):38-45. PubMed ID: 33180355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemostasis in Pediatric Extracorporeal Life Support: Overview and Challenges.
    Martin AA; Bhat R; Chitlur M
    Pediatr Clin North Am; 2022 Jun; 69(3):441-464. PubMed ID: 35667756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of device thrombus in the HeartWare HVAD: Success and outcomes depend significantly on the initial treatment strategy.
    Stulak JM; Dunlay SM; Sharma S; Haglund NA; Davis MB; Cowger J; Shah P; Masood F; Aaronson KD; Pagani FD; Maltais S
    J Heart Lung Transplant; 2015 Dec; 34(12):1535-41. PubMed ID: 26681123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Argatroban anticoagulation for heparin induced thrombocytopenia in patients with ventricular assist devices.
    Pappalardo F; Scandroglio AM; Potapov E; Stepanenko A; Maj G; Krabatsch T; Zangrillo A; Koster A; Hetzer R
    Minerva Anestesiol; 2012 Mar; 78(3):330-5. PubMed ID: 22357371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aniticoagulation in patients following prosthetic heart valve replacement.
    Akhtar RP; Abid AR; Zafar H; Khan JS
    Ann Thorac Cardiovasc Surg; 2009 Feb; 15(1):10-7. PubMed ID: 19262444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement in survival after mechanical circulatory support with pneumatic pulsatile ventricular assist devices in pediatric patients.
    Hetzer R; Potapov EV; Stiller B; Weng Y; Hübler M; Lemmer J; Alexi-Meskishvili V; Redlin M; Merkle F; Kaufmann F; Hennig E
    Ann Thorac Surg; 2006 Sep; 82(3):917-24; discussion 924-5. PubMed ID: 16928509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of a modified anti-thrombotic guideline on stroke in children supported with a pediatric ventricular assist device.
    Rosenthal DN; Lancaster CA; McElhinney DB; Chen S; Stein M; Lin A; Doan L; Murray JM; Gowan MA; Maeda K; Reinhartz O; Almond CS
    J Heart Lung Transplant; 2017 Nov; 36(11):1250-1257. PubMed ID: 28606584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conservative approaches for HeartWare ventricular assist device pump thrombosis may improve the outcome compared with immediate surgical approaches.
    Saeed D; Maxhera B; Albert A; Westenfeld R; Hoffmann T; Lichtenberg A
    Interact Cardiovasc Thorac Surg; 2016 Jul; 23(1):90-5. PubMed ID: 26993475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What is the optimal anticoagulation in patients with a left ventricular assist device?
    Rossi M; Serraino GF; Jiritano F; Renzulli A
    Interact Cardiovasc Thorac Surg; 2012 Oct; 15(4):733-40. PubMed ID: 22761118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired von Willebrand syndrome in patients with a centrifugal or axial continuous flow left ventricular assist device.
    Meyer AL; Malehsa D; Budde U; Bara C; Haverich A; Strueber M
    JACC Heart Fail; 2014 Apr; 2(2):141-5. PubMed ID: 24720921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.